Accuray Incorporated Financials
| ARAY Stock | USD 1.86 0.01 0.54% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.39 | 1.49 |
|
|
Investors should never underestimate Accuray Incorporated's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Accuray Incorporated's cash flow, debt, and profitability to make informed and accurate decisions about investing in Accuray Incorporated.
Net Income |
|
Accuray | Select Account or Indicator |
Understanding current and past Accuray Incorporated Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Accuray Incorporated's financial statements are interrelated, with each one affecting the others. For example, an increase in Accuray Incorporated's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Accuray Incorporated's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Accuray Incorporated. Check Accuray Incorporated's Beneish M Score to see the likelihood of Accuray Incorporated's management manipulating its earnings.
Accuray Incorporated Stock Summary
Accuray Incorporated competes with SurModics, Axogen, Bioventus, Paragon 28, and Orthofix Medical. Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California. Accuray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1044 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US0043971052 |
| CUSIP | 004397105 |
| Location | California; U.S.A |
| Business Address | 1240 Deming Way, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.accuray.com |
| Phone | 608 824 2800 |
| Currency | USD - US Dollar |
Accuray Incorporated Key Financial Ratios
| Return On Equity | -0.0915 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.04 % | ||||
| Price To Sales | 0.42 X | ||||
| Revenue | 446.55 M |
Accuray Incorporated Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 480.1M | 472.8M | 479.2M | 468.6M | 538.9M | 394.4M | |
| Net Debt | 83.0M | 125.0M | 115.6M | 142.2M | 163.5M | 171.7M | |
| Cash | 116.4M | 88.7M | 89.4M | 68.6M | 78.9M | 84.2M | |
| Other Assets | 17.1M | 18.1M | 20.5M | 21.4M | 19.2M | 14.0M | |
| Total Liab | 411.3M | 419.7M | 425.6M | 423.5M | 487.1M | 314.4M | |
| Total Current Assets | 352.8M | 350.9M | 338.0M | 323.2M | 371.7M | 285.1M | |
| Other Current Liab | 71.1M | 68.2M | 66.3M | 47.0M | 54.0M | 46.4M | |
| Other Liab | 31.5M | 31.5M | 14.2M | 31.8M | 28.6M | 27.4M | |
| Retained Earnings | (488.0M) | (492.5M) | (502.1M) | (517.7M) | (465.9M) | (489.2M) | |
| Accounts Payable | 19.5M | 31.3M | 33.7M | 50.0M | 57.5M | 60.4M | |
| Net Receivables | 85.4M | 94.4M | 74.8M | 92.0M | 105.8M | 66.8M | |
| Good Will | 58.0M | 57.8M | 57.7M | 57.7M | 66.3M | 46.0M | |
| Inventory | 125.9M | 142.3M | 145.2M | 138.3M | 159.1M | 93.8M | |
| Other Current Assets | 25.1M | 25.5M | 28.7M | 24.3M | 28.0M | 28.1M | |
| Short Term Debt | 20.1M | 25.7M | 14.0M | 20.2M | 23.2M | 22.1M | |
| Intangible Assets | 435K | 250K | 210K | 59K | 53.1K | 50.4K | |
| Net Tangible Assets | 5.3M | 10.4M | (4.9M) | (11.7M) | (10.6M) | (10.0M) | |
| Long Term Debt | 170.0M | 171.9M | 171.6M | 164.4M | 189.1M | 174.0M | |
| Long Term Debt Total | 159.8M | 189.3M | 170.0M | 171.9M | 197.7M | 172.1M | |
| Capital Surpluse | 535.3M | 545.7M | 554.7M | 543.2M | 624.7M | 543.6M |
Accuray Incorporated Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 16.9M | 8.1M | 10.6M | 11.6M | 13.4M | 8.6M | |
| Total Revenue | 396.3M | 429.9M | 447.6M | 446.6M | 513.5M | 302.7M | |
| Gross Profit | 159.5M | 160.0M | 154.0M | 142.9M | 164.4M | 119.7M | |
| Operating Income | 15.8M | 2.6M | 2.4M | 504K | 579.6K | 608.6K | |
| Ebit | 22.2M | 8.1M | 2.4M | (196K) | (225.4K) | (236.7K) | |
| Ebitda | 28.6M | 13.7M | 6.9M | 5.7M | 6.6M | 6.9M | |
| Income Before Tax | (4.6M) | (2.0M) | (6.8M) | (11.8M) | (13.6M) | (14.3M) | |
| Income Tax Expense | 1.8M | 3.3M | 2.5M | 3.7M | 4.3M | 4.5M | |
| Research Development | 52.7M | 57.8M | 57.1M | 49.7M | 57.2M | 50.0M | |
| Cost Of Revenue | 236.8M | 270.0M | 293.6M | 303.6M | 349.2M | 200.4M | |
| Net Income | (6.3M) | (5.3M) | (9.3M) | (15.5M) | (17.9M) | (18.8M) | |
| Tax Provision | 1.8M | 3.3M | 2.5M | 3.7M | 4.3M | 2.4M | |
| Net Interest Income | (16.9M) | (8.1M) | (10.6M) | (11.6M) | (13.4M) | (14.0M) |
Accuray Incorporated Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Accuray Incorporated. It measures of how well Accuray is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Accuray Incorporated brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Accuray had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Accuray Incorporated has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 1.7M | (22.9M) | (6.9M) | (4.0M) | (3.6M) | (3.8M) | |
| Change In Cash | 8.3M | (28.0M) | 1.0M | (20.8M) | (18.7M) | (17.8M) | |
| Free Cash Flow | 36.2M | (7.1M) | 2.9M | (15.5M) | (17.8M) | (18.7M) | |
| Depreciation | 6.4M | 5.5M | 4.5M | 5.9M | 6.8M | 12.4M | |
| Other Non Cash Items | 21.4M | 7.6M | 5.2M | 8.8M | 10.1M | 10.4M | |
| Capital Expenditures | 2.3M | 4.7M | 12.7M | 3.6M | 3.2M | 5.8M | |
| Net Income | (6.3M) | (5.3M) | (9.3M) | (15.5M) | (17.9M) | (18.8M) | |
| End Period Cash Flow | 118.2M | 90.2M | 91.2M | 70.4M | 81.0M | 94.6M | |
| Change Receivables | (46.2M) | 19.0M | 5.2M | (12.5M) | (11.3M) | (10.7M) | |
| Net Borrowings | 24.5M | (17.4M) | (15M) | (3.9M) | (3.5M) | (3.3M) | |
| Change To Netincome | 12.8M | 17.2M | 15.9M | 6.6M | 7.6M | 7.3M | |
| Investments | (79K) | (4.7M) | (12.7M) | (3.6M) | (4.1M) | (4.3M) |
Accuray Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accuray Incorporated's current stock value. Our valuation model uses many indicators to compare Accuray Incorporated value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accuray Incorporated competition to find correlations between indicators driving Accuray Incorporated's intrinsic value. More Info.Accuray Incorporated is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Accuray Incorporated's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Accuray Incorporated's earnings, one of the primary drivers of an investment's value.Accuray Incorporated Systematic Risk
Accuray Incorporated's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Accuray Incorporated volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Accuray Incorporated correlated with the market. If Beta is less than 0 Accuray Incorporated generally moves in the opposite direction as compared to the market. If Accuray Incorporated Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Accuray Incorporated is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Accuray Incorporated is generally in the same direction as the market. If Beta > 1 Accuray Incorporated moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Accuray Incorporated Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Accuray Incorporated's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Accuray Incorporated growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Accuray Incorporated March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Accuray Incorporated help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Accuray Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of Accuray Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing Accuray Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Accuray Incorporated's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.92 | |||
| Information Ratio | 0.021 | |||
| Maximum Drawdown | 20.28 | |||
| Value At Risk | (6.28) | |||
| Potential Upside | 6.39 |
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.